| Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... The lancet Diabetes & endocrinology 8 (4), 301-312, 2020 | 189 | 2020 |
| Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes VR Curovic, T Suvitaival, I Mattila, L Ahonen, K Trošt, S Theilade, ... Diabetes 69 (10), 2217-2226, 2020 | 44 | 2020 |
| Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes V Rotbain Curovic, S Theilade, SA Winther, N Tofte, J Eugen-Olsen, ... Diabetes care 42 (6), 1112-1119, 2019 | 35 | 2019 |
| Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients V Rotbain Curovic, TW Hansen, MK Eickhoff, BJ von Scholten, ... Acta diabetologica 55, 1143-1150, 2018 | 31 | 2018 |
| Effect of liraglutide on expression of inflammatory genes in type 2 diabetes EH Zobel, RS Ripa, BJ von Scholten, V Rotbain Curovic, A Kjaer, ... Scientific reports 11 (1), 18522, 2021 | 26 | 2021 |
| Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial RS Ripa, EH Zobel, BJ von Scholten, JK Jensen, T Binderup, LJ Diaz, ... Circulation: Cardiovascular Imaging 14 (7), e012174, 2021 | 26 | 2021 |
| Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the … JK Jensen, EH Zobel, BJ von Scholten, V Rotbain Curovic, TW Hansen, ... Frontiers in Endocrinology 12, 790405, 2021 | 24 | 2021 |
| Ceramides and phospholipids are downregulated with liraglutide treatment: Results from the LiraFlame randomized controlled trial EH Zobel, A Wretlind, RS Ripa, VR Curovic, BJ von Scholten, T Suvitaival, ... BMJ Open Diabetes Research and Care 9 (1), e002395, 2021 | 15 | 2021 |
| Optimization of albuminuria-lowering treatment in Diabetes by crossover rotation to four different drug classes: a randomized crossover trial VR Curovic, N Jongs, MYAM Kroonen, EH Zobel, TW Hansen, T Sen, ... Diabetes care 46 (3), 593-601, 2023 | 12 | 2023 |
| Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes V Rotbain Curovic, S Theilade, SA Winther, N Tofte, L Tarnow, A Jorsal, ... Diabetic Medicine 38 (5), e14459, 2021 | 12 | 2021 |
| Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes LF Ferreira-Divino, T Suvitaival, V Rotbain Curovic, N Tofte, K Trošt, ... Cardiovascular Diabetology 21 (1), 135, 2022 | 11 | 2022 |
| Effect of Liraglutide on Vascular Inflammation Evaluated by [64Cu]DOTATATE EH Zobel, RS Ripa, BJ von Scholten, VR Curovic, LJ Diaz, TW Hansen, ... Diagnostics 11 (8), 1431, 2021 | 9 | 2021 |
| Liraglutide reduces cardiac adipose tissue in type 2 diabetes: a secondary analysis of the LIRAFLAME randomized placebo‐controlled trial IKB Rasmussen, EH Zobel, RS Ripa, BJ von Scholten, VR Curovic, ... Diabetes, Obesity and Metabolism 23 (12), 2651-2659, 2021 | 8 | 2021 |
| Urinary peptidome and diabetic retinopathy in the DIRECT‐Protect 1 and 2 trials V Rotbain Curovic, P Magalhães, T He, TW Hansen, H Mischak, ... Diabetic Medicine 38 (9), e14634, 2021 | 7 | 2021 |
| Declining incidence rates of distal symmetric polyneuropathy in people with type 1 and type 2 diabetes in Denmark, with indications of distinct patterns in type 1 diabetes HI Mizrak, TW Hansen, P Rossing, VR Curovic, D Vistisen, H Amadid, ... Diabetes Care 46 (11), 1997-2003, 2023 | 5 | 2023 |
| Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial VR Curovic, MK Eickhoff, T Rönkkö, M Frimodt-Møller, TW Hansen, ... Diabetes Care 45 (11), 2662-2668, 2022 | 5 | 2022 |
| Albuminuria‐lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo‐controlled study S Sivalingam, VS Wasehuus, V Rotbain Curovic, MB Blond, TW Hansen, ... Diabetes, Obesity and Metabolism 26 (1), 54-64, 2024 | 3 | 2024 |
| Acute and long-term treatment with dapagliflozin and association with serum soluble urokinase plasminogen activator receptor V Rotbain Curovic, MB Houlind, TW Hansen, J Eugen-Olsen, JC Laursen, ... Frontiers in Pharmacology 13, 799915, 2022 | 3 | 2022 |
| Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials A Wretlind, VR Curovic, A de Zawadzki, T Suvitaival, J Xu, EH Zobel, ... Lipids in Health and Disease 22 (1), 160, 2023 | 2 | 2023 |
| Performance of the 2009 CKDEPI, 2021 CKDEPI, and EKFC equations among high-risk patients in Denmark MB Houlind, E Iversen, VR Curovic, MB Jørgensen, A Andersen, ... Clinical Chemistry and Laboratory Medicine (CCLM) 61 (10), e192-e195, 2023 | 2 | 2023 |
Peter RossingSteno Diabetes CenterVerificeret mail på dadlnet.dk
